Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide ...

An updated framework for addressing traumatic brain injury places the focus on the acute phase, while considering internal, external and modifying factors that influence outcomes from these events, ...

Lack of transparency in clinical pathway development has been raised previously as a concern and is an important consideration for buy in of the pathway. 2 No information is provided to understand the ...

Subgroup analyses suggest that select patients with distal or medium artery strokes may benefit from endovascular treatment, ...

We sought to determine the proportion of participants with transient or minor neurological symptoms who had MRI evidence of acute ischemia at different clinical probabilities of transient ischemic ...

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and ...

Revalesio, a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders, today announced data from a post hoc analysis of its completed Phase 2 RESCUE ...